Fresenius Group Overview

22.04.2018

DGAP Ad-hoc - Fresenius SE & Co. KGaA: Fresenius terminates merger agreement with Akorn

  • Contact

    Markus Georgi

    Senior Vice President Investor Relations
    T: +49 (0) 6172 608-2485
    markus.georgi@fresenius.com

Fresenius SE & Co. KGaA: Fresenius terminates merger agreement with Akorn

Fresenius SE & Co. KGaA / Key word(s): Mergers & Acquisitions
Fresenius SE & Co. KGaA: Fresenius terminates merger agreement with Akorn

22-Apr-2018 / 19:00 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Fresenius terminates merger agreement with Akorn

Fresenius has decided today to terminate the company's merger agreement with Akorn, due to Akorn's failure to fulfill several closing conditions.

Fresenius' decision is based on, among other factors, material breaches of FDA1 data integrity requirements relating to Akorn's operations found during Fresenius' independent investigation. Fresenius offered to delay its decision in order to allow Akorn additional opportunity to complete its own investigation and present any information it wished Fresenius to consider, but Akorn has declined that offer.

1 FDA: Food and Drug Administration

Fresenius SE & Co. KGaA,
represented by Fresenius Management SE,
The Management Board

Bad Homburg v.d.H., April 22, 2018
----------------------------------------
Contact:
Markus Georgi
Senior Vice President Investor Relations
T: +49 (0) 6172 608-2485
markus.georgi@fresenius.com
----------------------------------------

End of note


22-Apr-2018 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this